semaglutide .125 dose Doubling Helps Get HbA1c Under Control No more confusion — the

The findings also suggested the risk signal was nearly five times stronger for Wegovy than for Ozempic

[4] Changes in physical activity levels often accompany GLP-1 treatment

Baseline assessment should include current thyroid status with TSH, free T4, and free T3 levels, documentation of Graves disease treatment history and current management, assessment of thyroid eye disease or other complications, cardiovascular evaluation including heart rate and rhythm (as both hyperthyroidism and GLP-1 receptor agonists can affect heart rate), and standard metabolic parameters including HbA1c, lipid profile, and renal function

These results are particularly relevant for individuals who have reached a plateau with earlier therapies